PB
Psyence Biomedical Ltd.
PBM · NASDAQ
$6.63 +4.83% (+$0.31)
1M +57.11%
Market Cap $126.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.01x
EV/FFO N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 58.93%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 39.48%
Asset turnover 0.00x
ROIC 36.81%
Debt
69 /100
Low Current ratio 14.62x
Int. coverage -727.46x
Debt/Equity 0.00x
Stability
6 /100
Unstable EPS volatility 666.33%
Profitable years 0
Beta 1.72x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre PBM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jody Aufrichtig
Employees
12
Headquarters
Toronto